标题
A Systematic Review on COVID-19 Vaccine Strategies, Their Effectiveness, and Issues
作者
关键词
-
出版物
Vaccines
Volume 9, Issue 12, Pages 1387
出版商
MDPI AG
发表日期
2021-12-01
DOI
10.3390/vaccines9121387
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Application of Nanotechnology in the COVID-19 Pandemic
- (2021) Dongki Yang International Journal of Nanomedicine
- Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK
- (2021) Julian W. Tang et al. JOURNAL OF INFECTION
- Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice
- (2021) Jing-Hui Tian et al. Nature Communications
- Strategies for Vaccination: Conventional Vaccine Approaches Versus New-Generation Strategies in Combination with Adjuvants
- (2021) Abdellatif Bouazzaoui et al. Pharmaceutics
- Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals
- (2021) Charlotte Manisty et al. LANCET
- Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
- (2021) Denis Y Logunov et al. LANCET
- Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
- (2021) Zhiwei Wu et al. LANCET INFECTIOUS DISEASES
- Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial
- (2021) Raches Ella et al. LANCET INFECTIOUS DISEASES
- Development and performance evaluation of a rapid in-house ELISA for retrospective serosurveillance of SARS-CoV-2
- (2021) Bijon Kumar Sil et al. PLoS One
- A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine
- (2021) Laurence Chu et al. VACCINE
- Th1 Skewed immune response of Whole Virion Inactivated SARS CoV 2 Vaccine and its safety evaluation
- (2021) Brunda Ganneru et al. iScience
- Immunogenicity and protective efficacy of BBV152, whole virion inactivated SARS- CoV-2 vaccine candidates in the Syrian hamster model
- (2021) Sreelekshmy Mohandas et al. iScience
- Nano-Enabled COVID-19 Vaccines: Meeting the Challenges of Durable Antibody Plus Cellular Immunity and Immune Escape
- (2021) André E. Nel et al. ACS Nano
- Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH
- (2021) Johannes Oldenburg et al. Hamostaseologie
- Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP
- (2021) Laura Solforosi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B.1.1.7 variant of SARS-CoV-2
- (2021) Gajanan N Sapkal et al. JOURNAL OF TRAVEL MEDICINE
- Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data
- (2021) Eric J Haas et al. LANCET
- Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
- (2021) Katherine R W Emary et al. LANCET
- Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study
- (2021) Jingxin Li et al. NATURE MEDICINE
- Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2
- (2021) Joseph E. Ebinger et al. NATURE MEDICINE
- Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Shabir A. Madhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody Responses after a Single Dose of SARS-CoV-2 mRNA Vaccine
- (2021) Todd Bradley et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 vaccine rumors and conspiracy theories: The need for cognitive inoculation against misinformation to improve vaccine adherence
- (2021) Md Saiful Islam et al. PLoS One
- COVID-19 Pandemic: Review of Contemporary and Forthcoming Detection Tools
- (2021) Mumtarin Jannat Oishee et al. Infection and Drug Resistance
- Effective public health measures to mitigate the spread of COVID-19: a systematic review
- (2021) Imen Ayouni et al. BMC PUBLIC HEALTH
- Antibody response induced by the BNT162b2 mRNA COVID-19 vaccine in a cohort of health-care workers, with or without prior SARS-CoV-2 infection: a prospective study
- (2021) Dora Buonfrate et al. CLINICAL MICROBIOLOGY AND INFECTION
- Serum antibody response to BNT162b2 after natural SARS‐CoV‐2 infection
- (2021) Thomas Perkmann et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Detection of SARS-CoV-2 by antigen ELISA test is highly swayed by viral load and sample storage condition
- (2021) Nihad Adnan et al. Expert Review of Anti-Infective Therapy
- Antibody response to the first dose of AZD1222 vaccine in COVID-19 convalescent and uninfected individuals in Bangladesh
- (2021) Raeed Jamiruddin et al. Expert Review of Vaccines
- Disproportionate COVID-19 vaccine acceptance rate among healthcare professionals on the eve of nationwide vaccine distribution in Bangladesh
- (2021) A.B.M. Muksudul Alam et al. Expert Review of Vaccines
- Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy
- (2021) Cengiz Karacin et al. Future Oncology
- COVID‐19 vaccines and nanomedicine
- (2021) Robert S. Shapiro INTERNATIONAL JOURNAL OF DERMATOLOGY
- AuNP Coupled Rapid Flow-Through Dot-Blot Immuno-Assay for Enhanced Detection of SARS-CoV-2 Specific Nucleocapsid and Receptor Binding Domain IgG
- (2021) Bijon Kumar Sil et al. International Journal of Nanomedicine
- Discovery of a SARS-CoV-2 variant from the P.1 lineage harboring K417T/E484K/N501Y mutations in Kofu, Japan
- (2021) Yosuke Hirotsu et al. JOURNAL OF INFECTION
- Systematic review of empirical studies comparing the effectiveness of non-pharmaceutical interventions against COVID-19
- (2021) Alba Mendez-Brito et al. JOURNAL OF INFECTION
- Neutralization of alpha, gamma, and D614G SARS‐CoV‐2 variants by CoronaVac vaccine‐induced antibodies
- (2021) Jorge Fernández et al. JOURNAL OF MEDICAL VIROLOGY
- Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin
- (2021) Pragya D Yadav et al. JOURNAL OF TRAVEL MEDICINE
- Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial
- (2021) Xinxue Liu et al. LANCET
- Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination
- (2021) Emma C Wall et al. LANCET
- Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey
- (2021) Mine Durusu Tanriover et al. LANCET
- Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial
- (2021) Shipo Wu et al. LANCET INFECTIOUS DISEASES
- Partial protection of Sinopharm vaccine against SARS COV2 during recent outbreak in Bahrain
- (2021) Mohamed Jahromi et al. MICROBIAL PATHOGENESIS
- Role of nanotechnology behind the success of mRNA vaccines for COVID-19
- (2021) Amit Khurana et al. Nano Today
- mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar
- (2021) Hiam Chemaitelly et al. NATURE MEDICINE
- Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial
- (2021) Ana C. Medeiros-Ribeiro et al. NATURE MEDICINE
- Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination
- (2021) Joana Barros-Martins et al. NATURE MEDICINE
- Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
- (2021) Robert W. Frenck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine
- (2021) Paul T. Heath et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety of administration of BNT162b2 mRNA (Pfizer‐BioNTech) COVID‐19 vaccine in youths and young adults with a history of acute lymphoblastic leukemia and allergy to PEG‐asparaginase
- (2021) Catherine Mark et al. PEDIATRIC BLOOD & CANCER
- Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderly
- (2021) Emire Seyahi et al. RHEUMATOLOGY INTERNATIONAL
- COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants
- (2021) Pinja Jalkanen et al. Nature Communications
- Heterologous immunization with Covishield and Pfizer vaccines against SARS-CoV-2 elicits a robust humoral immune response
- (2021) Ali Toloue Ostadgavahi et al. Journal of Infection in Developing Countries
- Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study
- (2021) Otavio T Ranzani et al. BMJ-British Medical Journal
- Comparison of immunogenicity and reactogenicity of inactivated SARS-CoV-2 vaccine (CoronaVac) in previously SARS-CoV-2 infected and uninfected health care workers
- (2021) Ahmet Soysal et al. Human Vaccines & Immunotherapeutics
- An Immunogenicity Report for the Comparison between Heterologous and Homologous Prime-Boost Schedules with ChAdOx1-S and BNT162b2 Vaccines
- (2021) Alexandre Vallée et al. Journal of Clinical Medicine
- Diagnostic Accuracy of Rapid Antigen Test Kits for Detecting SARS-CoV-2: A Systematic Review and Meta-Analysis of 17,171 Suspected COVID-19 Patients
- (2021) Shahad Saif Khandker et al. Journal of Clinical Medicine
- Age and Gender Disparities in Adverse Events Following COVID-19 Vaccination: Real-World Evidence Based on Big Data for Risk Management
- (2021) Xiaomo Xiong et al. Frontiers in Medicine
- Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing Hemodialysis
- (2021) Kevin Yau et al. JAMA Network Open
- Longitudinal Antibody Dynamics Against Structural Proteins of SARS-CoV-2 in Three COVID-19 Patients Shows Concurrent Development of IgA, IgM, and IgG
- (2021) Mohd Raeed Jamiruddin et al. Journal of Inflammation Research
- Genome Sequences of Two Novel Coronavirus (SARS-CoV-2) Isolates from Dhaka, Bangladesh
- (2021) M. Abdul Matin et al. Microbiology Resource Announcements
- Assessment of a rapid pan-antibody dot test for detection of antibodies against SARS-CoV-2
- (2021) Md Ahsanul Haq et al. Bangladesh Journal of Medical Science
- BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar
- (2021) Patrick Tang et al. NATURE MEDICINE
- Socio-demographic, psychological, and experiential predictors of COVID-19 vaccine hesitancy in South Korea, October-December 2020
- (2021) Seo Eun Hwang et al. Human Vaccines & Immunotherapeutics
- Presumed Asymptomatic Carrier Transmission of COVID-19
- (2020) Yan Bai et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany
- (2020) Camilla Rothe et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
- (2020) Qun Li et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevalence of antiphospholipid antibodies in Behçet's disease: A systematic review and meta-analysis
- (2020) Md Asiful Islam et al. PLoS One
- Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
- (2020) Timothy P. Sheahan et al. Nature Communications
- Opportunities and Challenges in the Delivery of mRNA-Based Vaccines
- (2020) Abishek Wadhwa et al. Pharmaceutics
- Chloroquine and Hydroxychloroquine for the Prevention or Treatment of Novel Coronavirus Disease (COVID-19) in Africa: Caution for Inappropriate Off-Label Use in Healthcare Settings
- (2020) Pascale M. Abena et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- COVID-19 challenge for modern medicine
- (2020) Tomasz Dzieciatkowski et al. Cardiology Journal
- A Genomic Perspective on the Origin and Emergence of SARS-CoV-2
- (2020) Yong-Zhen Zhang et al. CELL
- The Architecture of SARS-CoV-2 Transcriptome
- (2020) Dongwan Kim et al. CELL
- Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19
- (2020) Hin Chu et al. CLINICAL INFECTIOUS DISEASES
- Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
- (2020) Feng-Cai Zhu et al. LANCET
- Prevention and control of non-communicable diseases in the COVID-19 response
- (2020) Hans Henri P Kluge et al. LANCET
- The proximal origin of SARS-CoV-2
- (2020) Kristian G. Andersen et al. NATURE MEDICINE
- Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1
- (2020) Neeltje van Doremalen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cell entry mechanisms of SARS-CoV-2
- (2020) Jian Shang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Consideration of the Aerosol Transmission for COVID‐19 and Public Health
- (2020) Elizabeth L. Anderson et al. RISK ANALYSIS
- Reducing transmission of SARS-CoV-2
- (2020) Kimberly A. Prather et al. SCIENCE
- Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review
- (2020) Sasmita Poudel Adhikari et al. Infectious Diseases of Poverty
- Lower cost alternatives for molecular diagnosis of COVID-19: conventional RT-PCR and SYBR Green-based RT-qPCR
- (2020) Erick Gustavo Dorlass et al. BRAZILIAN JOURNAL OF MICROBIOLOGY
- Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
- (2020) Hui Wang et al. CELL
- Gold nanoparticles; potential nanotheranostic agent in breast cancer: a comprehensive review with systematic search strategy
- (2020) Shahad Saif Khandker et al. CURRENT DRUG METABOLISM
- Airborne transmission of SARS-CoV-2: The world should face the reality
- (2020) Lidia Morawska et al. ENVIRONMENT INTERNATIONAL
- Airborne Transmission of SARS-CoV-2
- (2020) Michael Klompas et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes
- (2020) Shengli Xia et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2020) Feng-Cai Zhu et al. LANCET
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- (2020) Pedro M Folegatti et al. LANCET
- Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults
- (2020) Mark J. Mulligan et al. NATURE
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection
- (2020) Kaja Abbas et al. Lancet Global Health
- Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2
- (2020) Chiara Robba et al. Expert Review of Respiratory Medicine
- Immunomodulatory Effects of Diet and Nutrients in Systemic Lupus Erythematosus (SLE): A Systematic Review
- (2020) Md Asiful Islam et al. Frontiers in Immunology
- COVID-19 and first trimester spontaneous abortion: a case-control study of 225 pregnant patients
- (2020) Stefano COSMA et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- mRNA Vaccine Era—Mechanisms, Drug Platform and Clinical Prospection
- (2020) Shuqin Xu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
- (2020) Peter W Horby et al. LANCET
- Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
- (2020) Denis Y Logunov et al. LANCET
- Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
- (2020) Shengli Xia et al. LANCET INFECTIOUS DISEASES
- The arrival of Sputnik V
- (2020) Vijay Shankar Balakrishnan LANCET INFECTIOUS DISEASES
- Viral load of SARS-CoV-2 across patients and compared to other respiratory viruses
- (2020) Damien Jacot et al. MICROBES AND INFECTION
- SARS-CoV-2 vaccines in development
- (2020) Florian Krammer NATURE
- Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
- (2020) Edward E. Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
- (2020) Cheryl Keech et al. NEW ENGLAND JOURNAL OF MEDICINE
- Challenges and prospects of COVID‐19 vaccine development based on the progress made in SARS and MERS vaccine development
- (2020) Jubeda Begum et al. Transboundary and Emerging Diseases
- Treatment of Immunocompromised COVID‐19 patients with Convalescent Plasma
- (2020) Monica Fung et al. Transplant Infectious Disease
- Vaccines based on replication incompetent Ad26 viral vectors: standardized template with key considerations for a risk/benefit assessment
- (2020) Jerome Custers et al. VACCINE
- Sequence analysis of SARS-CoV-2 genome reveals features important for vaccine design
- (2020) Jacob Kames et al. Scientific Reports
- A living WHO guideline on drugs for covid-19
- (2020) François Lamontagne et al. BMJ-British Medical Journal
- Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future
- (2020) Olayinka O. Ogunleye et al. Frontiers in Pharmacology
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
- (2020) Maheshi N Ramasamy et al. LANCET
- Nanoceria as a possible agent for the management of COVID-19
- (2020) Prince Allawadhi et al. Nano Today
- T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
- (2020) Katie J. Ewer et al. NATURE MEDICINE
- Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
- (2020) Jordan R. Barrett et al. NATURE MEDICINE
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevalence of symptoms of depression, anxiety, insomnia, posttraumatic stress disorder, and psychological distress among populations affected by the COVID-19 pandemic: A systematic review and meta-analysis
- (2020) Jude Mary Cénat et al. PSYCHIATRY RESEARCH
- Rapid review of suspected adverse drug events due to remdesivir in the WHO database; findings and implications
- (2020) Jaykaran Charan et al. Expert Review of Clinical Pharmacology
- Systematic Review on the Therapeutic Options for COVID-19: Clinical Evidence of Drug Efficacy and Implications
- (2020) Abdullahi Rabiu Abubakar et al. Infection and Drug Resistance
- Confidence and Receptivity for COVID-19 Vaccines: A Rapid Systematic Review
- (2020) Cheryl Lin et al. Vaccines
- Rapid Assessment of Price Instability and Paucity of Medicines and Protection for COVID-19 Across Asia: Findings and Public Health Implications for the Future
- (2020) Brian Godman et al. Frontiers in Public Health
- Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis
- (2020) Imad M. Tleyjeh et al. CLINICAL MICROBIOLOGY AND INFECTION
- Prevalence of mental health problems during the COVID-19 pandemic: A systematic review and meta-analysis
- (2020) Tianchen Wu et al. JOURNAL OF AFFECTIVE DISORDERS
- Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
- (2020) Yanjun Zhang et al. LANCET INFECTIOUS DISEASES
- Insights from nanotechnology in COVID-19 treatment
- (2020) Zhongmin Tang et al. Nano Today
- Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections
- (2020) Srinivasa Reddy Bonam et al. Nano Today
- Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial
- (2020) Andrew J Pollard et al. LANCET INFECTIOUS DISEASES
- mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials
- (2019) Robert A. Feldman et al. VACCINE
- Focus on Middle East respiratory syndrome coronavirus (MERS-CoV)
- (2019) A. Bleibtreu et al. MEDECINE ET MALADIES INFECTIEUSES
- Synthetic mRNA nanoparticle-mediated restoration of p53 tumor suppressor sensitizes p53-deficient cancers to mTOR inhibition
- (2019) Na Kong et al. Science Translational Medicine
- Innate immune responses triggered by nucleic acids inspire the design of immunomodulatory nucleic acid nanoparticles (NANPs)
- (2019) Morgan Chandler et al. CURRENT OPINION IN BIOTECHNOLOGY
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Applications and perspectives of nanomaterials in novel vaccine development
- (2018) Yingbin Shen et al. MedChemComm
- Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus
- (2018) Yao Deng et al. Emerging Microbes & Infections
- Recent research and development of PLGA/PLA microspheres/nanoparticles: A review in scientific and industrial aspects
- (2018) Feng Qi et al. Frontiers of Chemical Science and Engineering
- Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA
- (2018) Mohammad Ariful Islam et al. Nature Biomedical Engineering
- Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems
- (2017) S Guan et al. GENE THERAPY
- Induction of an IFN-Mediated Antiviral Response by a Self-Amplifying RNA Vaccine: Implications for Vaccine Design
- (2017) Timothy Pepini et al. JOURNAL OF IMMUNOLOGY
- Adjuvant effects of a sequence-engineered mRNA vaccine: translational profiling demonstrates similar human and murine innate response
- (2017) Darin K. Edwards et al. Journal of Translational Medicine
- Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques
- (2017) Frank Liang et al. MOLECULAR THERAPY
- Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
- (2017) Kapil Bahl et al. MOLECULAR THERAPY
- Immunogenicity and protective efficacy induced by self-amplifying mRNA vaccines encoding bacterial antigens
- (2017) Giulietta Maruggi et al. VACCINE
- Safety and Immunogenicity of Novel Adenovirus Type 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines
- (2016) Iain D. Milligan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Materials for non-viral intracellular delivery of messenger RNA therapeutics
- (2016) Kevin J. Kauffman et al. JOURNAL OF CONTROLLED RELEASE
- Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens
- (2016) Sam Afkhami et al. Molecular Therapy-Methods & Clinical Development
- Regulatory aspects on nanomedicines
- (2015) Vanessa Sainz et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes
- (2015) Norbert Pardi et al. JOURNAL OF CONTROLLED RELEASE
- Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals
- (2015) Andreas Thess et al. MOLECULAR THERAPY
- Adenovirus Vectors for Gene Therapy, Vaccination and Cancer Gene Therapy
- (2014) William Wold et al. CURRENT GENE THERAPY
- Non-viral vectors for gene-based therapy
- (2014) Hao Yin et al. NATURE REVIEWS GENETICS
- Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice
- (2014) Eun Kim et al. VACCINE
- Nanotechnology and vaccine development
- (2014) Mi-Gyeong Kim et al. Asian Journal of Pharmaceutical Sciences
- Targeting C-type lectin receptors with multivalent carbohydrate ligands
- (2013) Bernd Lepenies et al. ADVANCED DRUG DELIVERY REVIEWS
- Carbon nanotubes as vaccine scaffolds
- (2013) David A. Scheinberg et al. ADVANCED DRUG DELIVERY REVIEWS
- Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: Effect of mucoadhesive coating on antigen uptake and immune adjuvant activity
- (2013) Dilip Pawar et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation
- (2013) Bart L Haagmans et al. LANCET INFECTIOUS DISEASES
- Nanoparticle vaccines
- (2013) Liang Zhao et al. VACCINE
- Randomized, placebo-controlled trial to assess the safety and immunogenicity of an adenovirus type 35-based circumsporozoite malaria vaccine in healthy adults
- (2013) C Buddy Creech et al. Human Vaccines & Immunotherapeutics
- Vaccine delivery using nanoparticles
- (2013) Anthony E. Gregory et al. Frontiers in Cellular and Infection Microbiology
- Vaccine process technology
- (2012) Jessica O. Josefsberg et al. BIOTECHNOLOGY AND BIOENGINEERING
- A cationic vaccine adjuvant based on a saturated quaternary ammonium lipid have different in vivo distribution kinetics and display a distinct CD4 T cell-inducing capacity compared to its unsaturated analog
- (2012) Dennis Christensen et al. JOURNAL OF CONTROLLED RELEASE
- Characterization of Humoral and Cellular Immune Responses Elicited by a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine in Healthy Adults (IPCAVD 001)
- (2012) Dan H. Barouch et al. JOURNAL OF INFECTIOUS DISEASES
- The current challenges for vaccine development
- (2012) P. Oyston et al. JOURNAL OF MEDICAL MICROBIOLOGY
- AF03, An Alternative Squalene Emulsion‐Based Vaccine Adjuvant Prepared by a Phase Inversion Temperature Method
- (2012) Marie‐Françoise Klucker et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Discovery of Seven Novel Mammalian and Avian Coronaviruses in the Genus Deltacoronavirus Supports Bat Coronaviruses as the Gene Source of Alphacoronavirus and Betacoronavirus and Avian Coronaviruses as the Gene Source of Gammacoronavirus and Deltacoronavirus
- (2012) P. C. Y. Woo et al. JOURNAL OF VIROLOGY
- Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
- (2012) Ali M. Zaki et al. NEW ENGLAND JOURNAL OF MEDICINE
- Developing mRNA-vaccine technologies
- (2012) Thomas Schlake et al. RNA Biology
- A simple approach for enhanced immune response using engineered dendritic cell targeted nanoparticles
- (2012) Dharmendra Raghuwanshi et al. VACCINE
- Addressing the vaccine confidence gap
- (2011) Heidi J Larson et al. LANCET
- Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA
- (2011) Katalin Karikó et al. NUCLEIC ACIDS RESEARCH
- Design of a Protective Single-Dose Intranasal Nanoparticle-Based Vaccine Platform for Respiratory Infectious Diseases
- (2011) Bret D. Ulery et al. PLoS One
- Investigation of lectinized liposomes as M-cell targeted carrier-adjuvant for mucosal immunization
- (2010) Prem N. Gupta et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses
- (2010) Moses O Oyewumi et al. Expert Review of Vaccines
- Coronavirus Genomics and Bioinformatics Analysis
- (2010) Patrick C. Y. Woo et al. Viruses-Basel
- Targeted Delivery of Immunogen to Primate M Cells with Tetragalloyl Lysine Dendrimer
- (2009) Shogo Misumi et al. JOURNAL OF IMMUNOLOGY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines
- (2008) R. H. See et al. JOURNAL OF GENERAL VIROLOGY
- Genomic characterizations of bat coronaviruses (1A, 1B and HKU8) and evidence for co-infections in Miniopterus bats
- (2008) D. K. W. Chu et al. JOURNAL OF GENERAL VIROLOGY
- Identification of a Novel Coronavirus from a Beluga Whale by Using a Panviral Microarray
- (2008) K. A. Mihindukulasuriya et al. JOURNAL OF VIROLOGY
- Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
- (2008) Katalin Karikó et al. MOLECULAR THERAPY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started